These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6202339)

  • 21. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulators of cyclic AMP systems.
    Hess SM; Chasin M; Free CA; Harris DN
    Psychopharmacol Bull; 1975 Oct; 11(4):57-8. PubMed ID: 172934
    [No Abstract]   [Full Text] [Related]  

  • 23. Physostigmine inhibition of 3',5'-cyclic AMP phosphodiesterase from cat sciatic nerve.
    Curley WH; Standaert FG; Dretchen KL
    J Pharmacol Exp Ther; 1984 Mar; 228(3):656-61. PubMed ID: 6323676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
    Bartel S; Tenor H; Krause EG
    Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
    Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
    Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of alkylated xanthines on cyclic AMP accumulation in dog thyroid slices exposed to carbamylcholine.
    Miot F; Erneux C; Wells JN; Dumont JE
    Mol Pharmacol; 1984 Mar; 25(2):261-6. PubMed ID: 6321949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulators of cyclic AMP systems.
    Hess SM; Chasin M; Free CA; Harris DN
    Adv Biochem Psychopharmacol; 1975; (14):153-67. PubMed ID: 242200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Demonstration of functional compartments of cyclic AMP in rat platelets by the use of phosphodiesterase inhibitors.
    Ashida S; Sakuma K
    Adv Second Messenger Phosphoprotein Res; 1992; 25():229-39. PubMed ID: 1313259
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and enzymic activity of 6-carbethoxy- and 6-ethoxy-3,7-disubstituted-pyrazolo[1,5-a]pyrimidines and related derivatives as adenosine cyclic 3' ,5'-phosphate phosphodiesterase inhibitors.
    Springer RH; Scholten MB; O'Brien DE; Novinson T; Miller JP; Robins RK
    J Med Chem; 1982 Mar; 25(3):235-42. PubMed ID: 6279841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DN 9693: a phosphodiesterase inhibitor with a platelet membrane effect.
    Jackson C; Ball J; Peel J; Lawry J; Greaves M; Preston FE
    Thromb Haemost; 1989 Apr; 61(2):266-9. PubMed ID: 2546286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemorrheologic effects of pyrimido-pyrimidine derivatives.
    Ambrus JL; Stadler I; Kulaylat M; Koreshi A; Akhtar S
    J Med; 1996; 27(1-2):21-32. PubMed ID: 8863175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of isoenzyme-selective inhibitors of cyclic nucleotide phosphodiesterase on microvascular leak in guinea pig airways in vivo.
    Raeburn D; Karlsson JA
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1147-52. PubMed ID: 8263775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are phosphodiesterase 4 inhibitors just more theophylline?
    Boswell-Smith V; Cazzola M; Page CP
    J Allergy Clin Immunol; 2006 Jun; 117(6):1237-43. PubMed ID: 16750981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human platelet aggregation by dihydropyrano- and dihydrofuranocoumarins, a new class of cAMP-phosphodiesterase inhibitors.
    Thastrup O; Knudsen JB; Lemmich J; Winther K
    Biochem Pharmacol; 1985 Jun; 34(12):2137-40. PubMed ID: 2988567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Theophylline suppresses human alveolar macrophage respiratory burst through phosphodiesterase inhibition.
    Dent G; Giembycz MA; Rabe KF; Wolf B; Barnes PJ; Magnussen H
    Am J Respir Cell Mol Biol; 1994 May; 10(5):565-72. PubMed ID: 8179921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: Enhancement of ADP-induced platelet aggregation by isometric hand-grip excercise in sclerotic patients and its prevention by EG-626, cAMPPDE inhibitor.
    Sano T; Motimiya T; Yamazaki H; Shinamoto T
    Thromb Diath Haemorrh; 1975 Sep; 34(1):344. PubMed ID: 171796
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
    Sakamoto N; Terai M; Takenaka T; Maeno H
    Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclic GMP binding and phosphodiesterase: implication for platelet function.
    Hamet P; Coquil JF; Bousseau-Lafortune S; Franks DJ; Tremblay J
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():119-36. PubMed ID: 6202123
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
    Endoh M; Satoh K; Yamashita S
    Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ca2+-calmodulin-activated cyclic nucleotide phosphodiesterase from the soluble fraction of the human brain: Kinetic properties and the effect of the antidepressant pyrazidol and its nitro analog on the enzyme].
    Medvedeva MV; Belov AA; Kireeva NN; Bobruskin ID
    Biokhimiia; 1993 May; 58(5):798-808. PubMed ID: 8393348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.